http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007140244-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-12 |
| filingDate | 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007140244-A |
| titleOfInvention | DERIVATIVE COMPOUND OF PROPANE-1,3-DIONE OR ITS SALT |
| abstract | 1. The propan-1,3-dione derivative represented by the general formula (I) or a pharmaceutically acceptable salt thereof:! ! (where the symbols in the indicated formula have the following meanings:! A is an optionally substituted aryl or optionally substituted heteroaryl,! cycle B is a benzene ring or thiophene ring,! cycle C is a benzene ring or a 5-7 membered aliphatic hydrocarbon ring, optionally containing double bond,! R1 are the same or different and each represents a halogen, an optionally substituted hydrocarbon group, —O— (an optionally substituted hydrocarbon group), an optionally substituted heterocyclic group, —S- (optionally substituted hydrocarbon group), —CO— (optionally substituted hydrocarbon group), —CO2– (optionally substituted hydrocarbon group), —O — CO— (optionally substituted hydrocarbon group), —SO— (optionally substituted hydrocarbon group), —SO2- (optionally substituted hydrocarbon group), —NO2, —CN, —CO2H, optionally substituted carbamoyl, optionally substituted sulfamoyl or optionally substituted amino group! R2 are the same or different and each is halogen, R0, —O-R0 or a halogen-substituted lower al kil! m, n are the same or different and each represents 0, 1 or 2,! R3 is R0, —OH, —O — optionally substituted heteroaryl, —N (R51) (R52), —N (R73) —N (R74) (R75),! formulas 17! ! or together with R2, -N = C (R45) -NH- or -NH-C (R45) = N-,! cycle D means an optionally substituted heterocycle selected from the following group:! formulas 18! ! R0 are the same or different and each represents lower alkyl,! R00 are the same or different and each represents lower alkylene,! k - 1, 2, 3 or 4 |
| priorityDate | 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.